Vision Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$253K Hold
1,500
0.03% 131
2025
Q4
$253K Hold
1,500
0.03% 130
2025
Q3
$217K Buy
+1,500
New +$205K 0.03% 136

Other funds holding IBB

Vision Capital Management's IBB Position: Q1 2026 in Review

Vision Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,500 shares worth $253K. The position accounts for 0.03% of the portfolio, ranked #131.

Vision Capital Management first reported a position in IBB in Q3 2025 and has held it in 3 quarters since. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Vision Capital Management held 1,500 shares of iShares Biotechnology ETF worth $253K as of Q1 2026.
  • Vision Capital Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.03% of Vision Capital Management's portfolio in Q1 2026, its #131 holding.
  • Vision Capital Management first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 3 quarters since.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Vision Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.